Skip to main content
OpenTrials
Completed

NCT Number: NCT01295021

The Prevalence of Sympathetic Overactivity in Primary Hypertensive Patients.

The purpose of this NIS is to assess the prevalence of sympathetic overactivity in patients with newly diagnosed essential hypertension.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site, Agartala, India

Loading trial locations.

About this study

MC MD

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Newly diagnosed essential hypertension patients will be eligible for the study.
  • Average of two or more systolic BP readings ≥ 140mmHg or diastolic BP readings ≥ 90mmHg

Exclusion criteria

  • History of coronary artery disease
  • History of diabetes

Treatment and study plan

Primary outcomes

  1. Prevalence of SO in newly diagnosed hypertensive patients

    Time frame: Visit 1-3: heart rate & Blood pressure, treatment presribed by physician. The interval between visit 1 and visit 2 is upto 4 weeks and interval between visit 2 & visit 3 is upto 4 weeks depending on Investigators discretion.

Secondary outcomes

  1. Association of SO and heart rate.

    Time frame: Visits 1-3

  2. Subjective symptoms noticed by the doctor.

    Time frame: 1st visit

  3. To record the drugs used in the treatment of patients diagnosed with hypertension.

    Time frame: Visits 1-3

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

A Non Interventional, Cross Sectional, Study on the Prevalence of Sympathetic Overactivity in Hypertensive Patients.

Acronym: SORT

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Feb 14, 2011
Registry last updated
Jun 10, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.